Role of Tissue Factor in Cancer

REFERENCES

• Spicer E. K., Horton R., Bloem L., Bach R., Williams K. R., Guha A., Kraus J., Lin T. C., Nemerson Y., Konigsberg W. H. Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA. Proc Natl Acad Sci USA 1987; 84(15)5148–5152
   PubMed Web of Science ®Google Scholar
• Morrissey J. H., Fakhrai H., Edgington T. S. Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascade. Cell 1987; 50(1)129–135
   PubMed Web of Science ®Google Scholar
• Scarpati E. M., Wen D., Broze G. J., Jr., Miletich J. P., Flandermeyer R. R., Siegel N. R., Sadler J. E. Human tissue factor: cDNA sequence and chromosome localization of the gene. Biochemistry 1987; 26(17)5234–5238
   PubMed Web of Science ®Google Scholar
• Fisher K. L., Gorman C. M., Vehar G. A., O'Brien D. P., Lawn R. M. Cloning and expression of human tissue factor cDNA. Thromb Res 1987; 48(1)89–99
   PubMed Web of Science ®Google Scholar
• Bogdanov V. Y., Balasubramanian V., Hathcock J., Vele O., Lieb M., Nemerson Y. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med 2003; 9(4)458–462
   PubMed Web of Science ®Google Scholar
• Chand H. S., Ness S. A., Kisiel W. Identification of a novel human tissue factor splice variant that is upregulated in tumor cells. Int J Cancer 2006; 118(7)1713–1720
   PubMed Web of Science ®Google Scholar
• Edgington T. S., Mackman N., Brand K., Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemost 1991; 66(1)67–79
   PubMed Web of Science ®Google Scholar
• Taubman M. B., Marmur J. D., Rosenfield C. L., Guha A., Nichtberger S., Nemerson Y. Agonist-mediated tissue factor expression in cultured vascular smooth muscle cells. Role of Ca2+ mobilization and protein kinase C activation. J Clin Invest 1993; 91(2)547–552
   PubMed Web of Science ®Google Scholar
• Cui M. Z., Parry G. C., Edgington T. S., Mackman N. Regulation of tissue factor gene expression in epithelial cells. Induction by serum and phorbol 12-myristate 13-acetate. Arterioscler Thromb 1994; 14(5)807–814
   PubMedGoogle Scholar
• Mackman N. Regulation of the tissue factor gene. Faseb J 1995; 9(10)883–889
   PubMed Web of Science ®Google Scholar
• Eilertsen K. E., Osterud B. Tissue factor: (patho)physiology and cellular biology. Blood Coagul Fibrinolysis 2004; 15(7)521–538
   PubMed Web of Science ®Google Scholar
• Bugge T. H., Xiao Q., Kombrinck K. W., Flick M. J., Holmback K., Danton M. J., Colbert M. C., Witte D. P., Fujikawa K., Davie E. W., Degen J. L. Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation. Proc Natl Acad Sci USA 1996; 93(13)6258–6263
   PubMed Web of Science ®Google Scholar
• Toomey J. R., Kratzer K. E., Lasky N. M., Stanton J. J., Broze G. J., Jr. Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood 1996; 88(5)1583–1587
   PubMed Web of Science ®Google Scholar
• Carmeliet P., Mackman N., Moons L., Luther T., Gressens P., Van Vlaenderen I., Demunck H., Kasper M., Breier G., Evrard P., Muller M., Risau W., Edgington T., Collen D. Role of tissue factor in embryonic blood vessel development. Nature 1996; 383(6595)73–75
   PubMed Web of Science ®Google Scholar
• Osterud B., Rapaport S. I. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 1977; 74(12)5260–5264
   PubMed Web of Science ®Google Scholar
• Nemerson Y. Tissue factor and hemostasis. Blood 1988; 71(1)1–8
   PubMed Web of Science ®Google Scholar
• Komiyama Y., Pedersen A. H., Kisiel W. Proteolytic activation of human factors IX and X by recombinant human factor VIIa: effects of calcium, phospholipids, and tissue factor. Biochemistry 1990; 29(40)9418–9425
   PubMed Web of Science ®Google Scholar
• Mackman N., Tilley R. E., Key N. S. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol 2007; 27(8)1687–1693
   PubMed Web of Science ®Google Scholar
• Belting M., Ahamed J., Ruf W. Signaling of the tissue factor coagulation pathway in angiogenesis and cancer. Arterioscler Thromb Vasc Biol 2005; 25(8)1545–1550
   PubMed Web of Science ®Google Scholar
• Ruf W. Tissue factor and PAR signaling in tumor progression. Thromb Res 2007; 120(Suppl. 2)S7–S12
   PubMedGoogle Scholar
• Drake T. A., Morrissey J. H., Edgington T. S. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989; 134(5)1087–1097
   PubMed Web of Science ®Google Scholar
• Fleck R. A., Rao L. V., Rapaport S. I., Varki N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res 1990; 59(2)421–437
   PubMedGoogle Scholar
• Contrino J., Hair G., Kreutzer D. L., Rickles F. R. In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nature Med 1996; 2(2)209–215
   PubMed Web of Science ®Google Scholar
• Shoji M., Hancock W. W., Abe K., Micko C., Casper K. A., Baine R. M., Wilcox J. N., Danave I., Dillehay D. L., Matthews E., Contrino J., Morrissey J. H., Gordon S., Edgington T. S., Kudryk B., Kreutzer D. L., Rickles F. R. Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am J Pathol 1998; 152(2)399–411
   PubMed Web of Science ®Google Scholar
• Siddiqui F. A., Desai H., Amirkhosravi A., Amaya M., Francis J. L. The presence and release of tissue factor from human platelets. Platelets 2002; 13(4)247–253
   PubMed Web of Science ®Google Scholar
• Biro E., Sturk-Maquelin K. N., Vogel G. M., Meuleman D. G., Smit M. J., Hack C. E., Sturk A., Nieuwland R. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost 2003; 1(12)2561–2568
   PubMed Web of Science ®Google Scholar
• Sturk-Maquelin K. N., Nieuwland R., Romijn F. P., Eijsman L., Hack C. E., Sturk A. Pro- and non-coagulant forms of non-cell-bound tissue factor in vivo. J Thromb Haemost 2003; 1(9)1920–1926
   PubMed Web of Science ®Google Scholar
• Muller I., Klocke A., Alex M., Kotzsch M., Luther T., Morgenstern E., Zieseniss S., Zahler S., Preissner K., Engelmann B. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. Faseb J 2003; 17(3)476–478
   PubMed Web of Science ®Google Scholar
• Takano S., Tsuboi K., Tomono Y., Mitsui Y., Nose T. Tissue factor, osteopontin, alphavbeta3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression. Br J Cancer 2000; 82(12)1967–1973
   PubMed Web of Science ®Google Scholar
• Guan M., Jin J., Su B., Liu W. W., Lu Y. Tissue factor expression and angiogenesis in human glioma. Clin Biochemistry 2002; 35(4)321–325
   PubMed Web of Science ®Google Scholar
• Vrana J. A., Stang M. T., Grande J. P., Getz M. J. Expression of tissue factor in tumor stroma correlates with progression to invasive human breast cancer: paracrine regulation by carcinoma cell-derived members of the transforming growth factor beta family. Cancer Res 1996; 56(21)5063–5070
   PubMed Web of Science ®Google Scholar
• Ueno T., Toi M., Koike M., Nakamura S., Tominaga T. Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration. Br J Cancer 2000; 83(2)164–170
   PubMed Web of Science ®Google Scholar
• Koomagi R., Volm M. Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: correlation between tissue factor and angiogenesis. Int J Cancer 1998; 79(1)19–22
   PubMed Web of Science ®Google Scholar
• Sawada M., Miyake S., Ohdama S., Matsubara O., Masuda S., Yakumaru K., Yoshizawa Y. Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis. Br J Cancer 1999; 79(3–4)472–477
   PubMed Web of Science ®Google Scholar
• Rauch U., Antoniak S., Boots M., Schulze K., Goldin-Lang P., Stein H., Schultheiss H. P., Coupland S. E. Association of tissue-factor upregulation in squamous-cell carcinoma of the lung with increased tissue factor in circulating blood. Lancet Oncol 2005; 6(4)254
   PubMed Web of Science ®Google Scholar
• Hair G. A., Padula S., Zeff R., Schmeizl M., Contrino J., Kreutzer D. L., de Moerloose P., Boyd A. W., Stanley I., Burgess A. W., Rickles F. R. Tissue factor expression in human leukemic cells. Leukemia Res 1996; 20(1)1–11
   PubMed Web of Science ®Google Scholar
• Lopez-Pedrera C., Barbarroja N., Dorado G., Siendones E., Velasco F. Tissue factor as an effector of angiogenesis and tumor progression in hematological malignancies. Leukemia 2006; 20(8)1331–1340
   PubMed Web of Science ®Google Scholar
• Kataoka H., Uchino H., Asada Y., Hatakeyama K., Nabeshima K., Sumiyoshi A., Koono M. Analysis of tissue factor and tissue factor pathway inhibitor expression in human colorectal carcinoma cell lines and metastatic sublines to the liver. Int J Cancer 1997; 72(5)878–884
   PubMed Web of Science ®Google Scholar
• Shigemori C., Wada H., Matsumoto K., Shiku H., Nakamura S., Suzuki H. Tissue factor expression and metastatic potential of colorectal cancer. Thrombosis and Haemostasis 1998; 80(6)894–898
   PubMed Web of Science ®Google Scholar
• Seto S., Onodera H., Kaido T., Yoshikawa A., Ishigami S., Arii S., Imamura M. Tissue factor expression in human colorectal carcinoma: correlation with hepatic metastasis and impact on prognosis. Cancer 2000; 88(2)295–301
   PubMed Web of Science ®Google Scholar
• Nakasaki T., Wada H., Shigemori C., Miki C., Gabazza E. C., Nobori T., Nakamura S., Shiku H. Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer. Am J Hematol 2002; 69(4)247–254
   PubMed Web of Science ®Google Scholar
• Poon R. T., Lau C. P., Ho J. W., Yu W. C., Fan S. T., Wong J. Tissue factor expression correlates with tumor angiogenesis and invasiveness in human hepatocellular carcinoma. Clin Cancer Res 2003; 9(14)5339–5345
   PubMed Web of Science ®Google Scholar
• Kageshita T., Funasaka Y., Ichihashi M., Wakamatsu K., Ito S., Ono T. Tissue factor expression and serum level in patients with melanoma does not correlate with disease progression. Pigment cell research/sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society 2001; 14(3)195–200
   PubMedGoogle Scholar
• Depasquale I., Thompson W. D. Prognosis in human melanoma: PAR-1 expression is superior to other coagulation components and VEGF. Histopathology 2008; 52(4)500–509
   PubMed Web of Science ®Google Scholar
• Abdulkadir S. A., Carvalhal G. F., Kaleem Z., Kisiel W., Humphrey P. A., Catalona W. J., Milbrandt J. Tissue factor expression and angiogenesis in human prostate carcinoma. Hum Pathol 2000; 31(4)443–447
   PubMed Web of Science ®Google Scholar
• Ohta S., Wada H., Nakazaki T., Maeda Y., Nobori T., Shiku H., Nakamura S., Nagakawa O., Furuya Y., Fuse H. Expression of tissue factor is associated with clinical features and angiogenesis in prostate cancer. Anticancer Res 2002; 22(5)2991–2996
   PubMed Web of Science ®Google Scholar
• Akashi T., Furuya Y., Ohta S., Fuse H. Tissue factor expression and prognosis in patients with metastatic prostate cancer. Urology 2003; 62(6)1078–1082
   PubMed Web of Science ®Google Scholar
• Forster Y., Meye A., Albrecht S., Kotzsch M., Fussel S., Wirth M. P., Schwenzer B. Tissue specific expression and serum levels of human tissue factor in patients with urological cancer. Cancer Lett 2003; 193(1)65–73
   PubMed Web of Science ®Google Scholar
• Kakkar A. K., Lemoine N. R., Scully M. F., Tebbutt S., Williamson R. C. Tissue factor expression correlates with histological grade in human pancreatic cancer. Br J Surg 1995; 82(8)1101–1104
   PubMed Web of Science ®Google Scholar
• Ueda C., Hirohata Y., Kihara Y., Nakamura H., Abe S., Akahane K., Okamoto K., Itoh H., Otsuki M. Pancreatic cancer complicated by disseminated intravascular coagulation associated with production of tissue factor. J Gastroenterol 2001; 36(12)848–850
   PubMed Web of Science ®Google Scholar
• Nitori N., Ino Y., Nakanishi Y., Yamada T., Honda K., Yanagihara K., Kosuge T., Kanai Y., Kitajima M., Hirohashi S. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma. Clin Cancer Res 2005; 11(7)2531–2539
   PubMed Web of Science ®Google Scholar
• Khorana A. A., Ahrendt S. A., Ryan C. K., Francis C. W., Hruban R. H., Hu Y. C., Hostetter G., Harvey J., Taubman M. B. Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer. Clin Cancer Res 2007; 13(10)2870–2875
   PubMed Web of Science ®Google Scholar
• Han L. Y., Landen C. N., Jr., Kamat A. A., Lopez A., Bender D. P., Mueller P., Schmandt R., Gershenson D. M., Sood A. K. Preoperative serum tissue factor levels are an independent prognostic factor in patients with ovarian carcinoma. J Clin Oncol 2006; 24(5)755–761
   PubMed Web of Science ®Google Scholar
• Patry G., Hovington H., Larue H., Harel F., Fradet Y., Lacombe L. Tissue factor expression correlates with disease-specific survival in patients with node-negative muscle-invasive bladder cancer. Int J Cancer 2008; 122(7)1592–1597
   PubMed Web of Science ®Google Scholar
• Kaushal V., Mukunyadzi P., Siegel E. R., Dennis R. A., Johnson D. E., Kohli M. Expression of tissue factor in prostate cancer correlates with malignant phenotype. Appl Immunohistochem Mol Morphol 2008; 16(1)1–6
   PubMedGoogle Scholar
• Chand H. S., Kisiel W. Quantitative real-time reverse transcription polymerase chain reaction analysis of a novel tissue factor splice variant in select human solid tumors. J Thromb Haemost 2007; 5(3)640–641
   PubMed Web of Science ®Google Scholar
• Hobbs J. E., Zakarija A., Cundiff D. L., Doll J. A., Hymen E., Cornwell M., Crawford S. E., Liu N., Signaevsky M., Soff G. A. Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model. Thromb Res 2007; 120(Suppl. 2)S13–S21
   PubMedGoogle Scholar
• Khorana A. A. Malignancy, thrombosis and Trousseau: the case for an eponym. J Thromb Haemost 2003; 1(12)2463–2465
   PubMed Web of Science ®Google Scholar
• Otten H. M., Prins M. H. Venous thromboembolism and occult malignancy. Thromb Res 2001; 102(6)V187–V194
   PubMed Web of Science ®Google Scholar
• Maynard J. R., Dreyer B. E., Stemerman M. B., Pitlick F. A. Tissue-factor coagulant activity of cultured human endothelial and smooth muscle cells and fibroblasts. Blood 1977; 50(3)387–396
   PubMed Web of Science ®Google Scholar
• Colucci M., Balconi G., Lorenzet R., Pietra A., Locati D., Donati M. B., Semeraro N. Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 1983; 71(6)1893–1896
   PubMed Web of Science ®Google Scholar
• Bevilacqua M. P., Pober J. S., Majeau G. R., Cotran R. S., Gimbrone M. A., Jr. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med 1984; 160(2)618–623
   PubMed Web of Science ®Google Scholar
• Bevilacqua M. P., Pober J. S., Majeau G. R., Fiers W., Cotran R. S., Gimbrone M. A., Jr. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci USA 1986; 83(12)4533–4537
   PubMed Web of Science ®Google Scholar
• Tannenbaum S. H., Finko R., Cines D. B. Antibody and immune complexes induce tissue factor production by human endothelial cells. J Immunol 1986; 137(5)1532–1537
   PubMed Web of Science ®Google Scholar
• Szotowski B., Antoniak S., Poller W., Schultheiss H. P., Rauch U. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ Res 2005; 96(12)1233–1239
   PubMed Web of Science ®Google Scholar
• Bona R., Lee E., Rickles F. Tissue factor apoprotein: intracellular transport and expression in shed membrane vesicles. Thromb Res 1987; 48(4)487–500
   PubMed Web of Science ®Google Scholar
• Conkling P. R., Greenberg C. S., Weinberg J. B. Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes. Blood 1988; 72(1)128–133
   PubMed Web of Science ®Google Scholar
• Drake T. A., Ruf W., Morrissey J. H., Edgington T. S. Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line. J Cell Biol 1989; 109(1)389–395
   PubMed Web of Science ®Google Scholar
• Cermak J., Key N. S., Bach R. R., Balla J., Jacob H. S., Vercellotti G. M. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993; 82(2)513–520
   PubMed Web of Science ®Google Scholar
• Schwager I., Jungi T. W. Effect of human recombinant cytokines on the induction of macrophage procoagulant activity. Blood 1994; 83(1)152–160
   PubMed Web of Science ®Google Scholar
• Del Prete G., De Carli M., Lammel R. M., D'Elios M. M., Daniel K. C., Giusti B., Abbate R., Romagnani S. Th1 and Th2 T-helper cells exert opposite regulatory effects on procoagulant activity and tissue factor production by human monocytes. Blood 1995; 86(1)250–257
   PubMed Web of Science ®Google Scholar
• Gouault Heilmann M., Chardon E., Sultan C., Josso F. The procoagulant factor of leukaemic promyelocytes: demonstration of immunologic cross reactivity with human brain tissue factor. Br J Haematol 1975; 30(2)151–158
   PubMed Web of Science ®Google Scholar
• Dvorak H. F., Quay S. C., Orenstein N. S., Dvorak A. M., Hahn P., Bitzer A. M., Carvalho A. C. Tumor shedding and coagulation. Science (New York, N. Y.) 1981; 212(4497)923–924
   PubMed Web of Science ®Google Scholar
• Dvorak H. F., Van DeWater L., Bitzer A. M., Dvorak A. M., Anderson D., Harvey V. S., Bach R., Davis G. L., DeWolf W., Carvalho A. C. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells. Cancer Res 1983; 43(9)4434–4442
   PubMed Web of Science ®Google Scholar
• Wada H., Nagano T., Tomeoku M., Kuto M., Karitani Y., Deguchi K., Shirakawa S. Coagulant and fibrinolytic activities in the leukemic cell lysates. Thromb Res 1983; 30(4)315–322
   PubMed Web of Science ®Google Scholar
• Bastida E., Ordinas A., Escolar G., Jamieson G. A. Tissue factor in microvesicles shed from U87MG human glioblastoma cells induces coagulation, platelet aggregation, and thrombogenesis. Blood 1984; 64(1)177–184
   PubMed Web of Science ®Google Scholar
• Cozzolino F., Torcia M., Miliani A., Carossino A. M., Giordani R., Cinotti S., Filimberti E., Saccardi R., Bernabei P., Guidi G., et al. Potential role of interleukin-1 as the trigger for diffuse intravascular coagulation in acute nonlymphoblastic leukemia. Am J Med 1988; 84(2)240–250
   PubMed Web of Science ®Google Scholar
• Tanaka M. Induction of tissue factor-like activity of human monoblastic leukemia cell line by tumor necrosis factor-alpha. Thromb Res 1989; 56(2)201–211
   PubMed Web of Science ®Google Scholar
• Mueller B. M., Reisfeld R. A., Edgington T. S., Ruf W. Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc Natl Acad Sci USA 1992; 89(24)11832–11836
   PubMed Web of Science ®Google Scholar
• Zucchella M., Pacchiarini L., Meloni F., Ballabio P., Saporiti A., Brocchieri A., Grignani G. Effect of interferon alpha, interferon gamma and tumor necrosis factor on the procoagulant activity of human cancer cells. Haematologica 1993; 78(5)282–286
   PubMedGoogle Scholar
• Dolo V., Adobati E., Canevari S., Picone M. A., Vittorelli M. L. Membrane vesicles shed into the extracellular medium by human breast carcinoma cells carry tumor-associated surface antigens. Clin Exp Metastasis 1995; 13(4)277–286
   PubMed Web of Science ®Google Scholar
• Kim C. W., Lee H. M., Lee T. H., Kang C., Kleinman H. K., Gho Y. S. Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin. Cancer Res 2002; 62(21)6312–6317
   PubMed Web of Science ®Google Scholar
• Yu J. L., Rak J. W. Shedding of tissue factor (TF)-containing microparticles rather than alternatively spliced TF is the main source of TF activity released from human cancer cells. J Thromb Haemost 2004; 2(11)2065–2067
   PubMed Web of Science ®Google Scholar
• Rong Y., Post D. E., Pieper R. O., Durden D. L., Van Meir E. G., Brat D. J. PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma. Cancer Res 2005; 65(4)1406–1413
   PubMed Web of Science ®Google Scholar
• Kakkar A. K., DeRuvo N., Chinswangwatanakul V., Tebbutt S., Williamson R. C. Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor. Lancet 1995; 346(8981)1004–1005
   PubMed Web of Science ®Google Scholar
• Tesselaar M. E., Romijn F. P., Van Der Linden I. K., Prins F. A., Bertina R. M., Osanto S. Microparticle-associated tissue factor activity: a link between cancer and thrombosis?. J Thromb Haemost 2007; 5(3)520–527
   PubMed Web of Science ®Google Scholar
• Langer F., Chun F. K., Amirkhosravi A., Friedrich M., Leuenroth S., Eifrig B., Bokemeyer C., Francis J. L. Plasma tissue factor antigen in localized prostate cancer: distribution, clinical significance and correlation with haemostatic activation markers. Thromb Haemost 2007; 97(3)464–470
   PubMed Web of Science ®Google Scholar
• Camera M., Frigerio M., Toschi V., Brambilla M., Rossi F., Cottell D. C., Maderna P., Parolari A., Bonzi R., De Vincenti O., Tremoli E. Platelet activation induces cell-surface immunoreactive tissue factor expression, which is modulated differently by antiplatelet drugs. Arterioscler Thromb Vasc Biol 2003; 23(9)1690–1696
   PubMed Web of Science ®Google Scholar
• Key N. S., Slungaard A., Dandelet L., Nelson S. C., Moertel C., Styles L. A., Kuypers F. A., Bach R. R. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease. Blood 1998; 91(11)4216–4223
   PubMed Web of Science ®Google Scholar
• Giesen P. L., Rauch U., Bohrmann B., Kling D., Roque M., Fallon J. T., Badimon J. J., Himber J., Riederer M. A., Nemerson Y. Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA 1999; 96(5)2311–2315
   PubMed Web of Science ®Google Scholar
• Falati S., Gross P., Merrill-Skoloff G., Furie B. C., Furie B. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med 2002; 8(10)1175–1181
   PubMed Web of Science ®Google Scholar
• Celi A., Merrill-Skoloff G., Gross P., Falati S., Sim D. S., Flaumenhaft R., Furie B. C., Furie B. Thrombus formation: direct real-time observation and digital analysis of thrombus assembly in a living mouse by confocal and widefield intravital microscopy. J Thromb Haemost 2003; 1(1)60–68
   PubMed Web of Science ®Google Scholar
• Falati S., Liu Q., Gross P., Merrill-Skoloff G., Chou J., Vandendries E., Celi A., Croce K., Furie B. C., Furie B. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 2003; 197(11)1585–1598
   PubMed Web of Science ®Google Scholar
• Chou J., Mackman N., Merrill-Skoloff G., Pedersen B., Furie B. C., Furie B. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 2004; 104(10)3190–3197
   PubMed Web of Science ®Google Scholar
• Day S. M., Reeve J. L., Pedersen B., Farris D. M., Myers D. D., Im M., Wakefield T. W., Mackman N., Fay W. P. Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. Blood 2005; 105(1)192–198
   PubMed Web of Science ®Google Scholar
• Uno K., Homma S., Satoh T., Nakanishi K., Abe D., Matsumoto K., Oki A., Tsunoda H., Yamaguchi I., Nagasawa T., Yoshikawa H., Aonuma K. Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer. Br J Cancer 2007; 96(2)290–295
   PubMed Web of Science ®Google Scholar
• Kamikura Y., Wada H., Nobori T., Kobayashi T., Sase T., Nishikawa M., Ishikura K., Yamada N., Abe Y., Nishioka J., Nakano T., Shiku H. Elevated levels of leukocyte tissue factor mRNA in patients with venous thromboembolism. Thromb Res 2005; 116(4)307–312
   PubMed Web of Science ®Google Scholar
• Goldenberg N., Kahn S. R., Solymoss S. Markers of coagulation and angiogenesis in cancer-associated venous thromboembolism. J Clin Oncol 2003; 21(22)4194–4199
   PubMed Web of Science ®Google Scholar
• Zioncheck T. F., Roy S., Vehar G. A. The cytoplasmic domain of tissue factor is phosphorylated by a protein kinase C-dependent mechanism. J Biol Chem 1992; 267(6)3561–3564
   PubMed Web of Science ®Google Scholar
• Ahamed J., Belting M., Ruf W. Regulation of tissue factor-induced signaling by endogenous and recombinant tissue factor pathway inhibitor 1. Blood 2005; 105(6)2384–2391
   PubMed Web of Science ®Google Scholar
• Ahamed J., Ruf W. Protease-activated receptor 2-dependent phosphorylation of the tissue factor cytoplasmic domain. J Biol Chem 2004; 279(22)23038–23044
   PubMed Web of Science ®Google Scholar
• Muller M., Albrecht S., Golfert F., Hofer A., Funk R. H., Magdolen V., Flossel C., Luther T. Localization of tissue factor in actin-filament-rich membrane areas of epithelial cells. Exp Cell Res 1999; 248(1)136–147
   PubMed Web of Science ®Google Scholar
• Ott I., Fischer E. G., Miyagi Y., Mueller B. M., Ruf W. A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. J Cell Biol 1998; 140(5)1241–1253
   PubMed Web of Science ®Google Scholar
• Dorfleutner A., Hintermann E., Tarui T., Takada Y., Ruf W. Cross-talk of integrin alpha3beta1 and tissue factor in cell migration. Mol Biol Cell 2004; 15(10)4416–4425
   PubMed Web of Science ®Google Scholar
• Ott I., Weigand B., Michl R., Seitz I., Sabbari-Erfani N., Neumann F. J., Schomig A. Tissue factor cytoplasmic domain stimulates migration by activation of the GTPase Rac1 and the mitogen-activated protein kinase p38. Circulation 2005; 111(3)349–355
   PubMed Web of Science ®Google Scholar
• Abe K., Shoji M., Chen J., Bierhaus A., Danave I., Micko C., Casper K., Dillehay D. L., Nawroth P. P., Rickles F. R. Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. Proc Natl Acad Sci USA 1999; 96(15)8663–8668
   PubMed Web of Science ®Google Scholar
• Bromberg M. E., Bailly M. A., Konigsberg W. H. Role of protease-activated receptor 1 in tumor metastasis promoted by tissue factor. Thromb Haemost 2001; 86(5)1210–1214
   PubMed Web of Science ®Google Scholar
• Bromberg M. E., Konigsberg W. H., Madison J. F., Pawashe A., Garen A. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci USA 1995; 92(18)8205–8209
   PubMed Web of Science ®Google Scholar
• Bromberg M. E., Sundaram R., Homer R. J., Garen A., Konigsberg W. H. Role of tissue factor in metastasis: functions of the cytoplasmic and extracellular domains of the molecule. Thromb Haemost 1999; 82(1)88–92
   PubMed Web of Science ®Google Scholar
• Hembrough T. A., Swartz G. M., Papathanassiu A., Vlasuk G. P., Rote W. E., Green S. J., Pribluda V. S. Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism. Cancer Res 2003; 63(11)2997–3000
   PubMed Web of Science ®Google Scholar
• Mueller B. M., Ruf W. Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis. J Clin Invest 1998; 101(7)1372–1378
   PubMed Web of Science ®Google Scholar
• Ngo C. V., Picha K., McCabe F., Millar H., Tawadros R., Tam S. H., Nakada M. T., Anderson G. M. CNTO 859, a humanized anti-tissue factor monoclonal antibody, is a potent inhibitor of breast cancer metastasis and tumor growth in xenograft models. Int J Cancer 2007; 120(6)1261–1267
   PubMed Web of Science ®Google Scholar
• Amarzguioui M., Peng Q., Wiiger M. T., Vasovic V., Babaie E., Holen T., Nesland J. M., Prydz H. Ex vivo and in vivo delivery of anti-tissue factor short interfering RNA inhibits mouse pulmonary metastasis of B16 melanoma cells. Clin Cancer Res 2006; 12(13)4055–4061
   PubMed Web of Science ®Google Scholar
• Zhang Y., Deng Y., Luther T., Muller M., Ziegler R., Waldherr R., Stern D. M., Nawroth P. P. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest 1994; 94(3)1320–1327
   PubMed Web of Science ®Google Scholar
• Belting M., Dorrell M. I., Sandgren S., Aguilar E., Ahamed J., Dorfleutner A., Carmeliet P., Mueller B. M., Friedlander M., Ruf W. Regulation of angiogenesis by tissue factor cytoplasmic domain signaling. Nat Med 2004; 10(5)502–509
   PubMed Web of Science ®Google Scholar
• Versteeg H. H., Schaffner F., Kerver M., Petersen H. H., Ahamed J., Felding-Habermann B., Takada Y., Mueller B. M., Ruf W. Inhibition of tissue factor signaling suppresses tumor growth. Blood 2008; 111(1)190–199
   PubMed Web of Science ®Google Scholar
• Palumbo J. S., Talmage K. E., Massari J. V., La Jeunesse C. M., Flick M. J., Kombrinck K. W., Hu Z., Barney K. A., Degen J. L. Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms. Blood 2007; 110(1)133–141
   PubMed Web of Science ®Google Scholar
• Toomey J. R., Kratzer K. E., Lasky N. M., Broze G. J., Jr. Effect of tissue factor deficiency on mouse and tumor development. Proc Natl Acad Sci USA 1997; 94(13)6922–6926
   PubMed Web of Science ®Google Scholar
• Parry G. C., Erlich J. H., Carmeliet P., Luther T., Mackman N. Low levels of tissue factor are compatible with development and hemostasis in mice. J Clin Invest 1998; 101(3)560–569
   PubMed Web of Science ®Google Scholar
• Milsom C., Yu J., May L., Meehan B., Magnus N., Al-Nedawi K., Luyendyk J., Weitz J., Klement P., Broze G., Mackman N., Rak J. The role of tumor-and host-related tissue factor pools in oncogene-driven tumor progression. Thromb Res 2007; 120(Suppl. 2)S82–S91
   PubMedGoogle Scholar
• Sorensen B. B., Freskgard P. O., Nielsen L. S., Rao L. V., Ezban M., Petersen L. C. Factor VIIa-induced p44/42 mitogen-activated protein kinase activation requires the proteolytic activity of factor VIIa and is independent of the tissue factor cytoplasmic domain. J Biol Chem 1999; 274(30)21349–21354
   PubMed Web of Science ®Google Scholar
• Camerer E., Rottingen J. A., Gjernes E., Larsen K., Skartlien A. H., Iversen J. G., Prydz H. Coagulation factors VIIa and Xa induce cell signaling leading to up-regulation of the egr-1 gene. J Biol Chem 1999; 274(45)32225–32233
   PubMed Web of Science ®Google Scholar
• Petersen L. C., Freskgard P., Ezban M. Tissue factor-dependent factor VIIa signaling. Trends Cardiovasc Med 2000; 10(2)47–52
   PubMed Web of Science ®Google Scholar
• Bono F., Schaeffer P., Herault J. P., Michaux C., Nestor A. L., Guillemot J. C., Herbert J. M. Factor Xa activates endothelial cells by a receptor cascade between EPR-1 and PAR-2. Arterioscler Thromb Vasc Biol 2000; 20(11)E107–E112
   PubMed Web of Science ®Google Scholar
• Camerer E., Huang W., Coughlin S. R. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci USA 2000; 97(10)5255–5260
   PubMed Web of Science ®Google Scholar
• Hjortoe G. M., Petersen L. C., Albrektsen T., Sorensen B. B., Norby P. L., Mandal S. K., Pendurthi U. R., Rao L. V. Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration. Blood 2004; 103(8)3029–3037
   PubMed Web of Science ®Google Scholar
• Petersen L. C., Thastrup O., Hagel G., Sorensen B. B., Freskgard P. O., Rao L. V., Ezban M. Exclusion of known protease-activated receptors in factor VIIa-induced signal transduction. Thromb Haemost 2000; 83(4)571–576
   PubMed Web of Science ®Google Scholar
• Siegbahn A., Johnell M., Rorsman C., Ezban M., Heldin C. H., Ronnstrand L. Binding of factor VIIa to tissue factor on human fibroblasts leads to activation of phospholipase C and enhanced PDGF-BB-stimulated chemotaxis. Blood 2000; 96(10)3452–3458
   PubMed Web of Science ®Google Scholar
• Cunningham M. A., Romas P., Hutchinson P., Holdsworth S. R., Tipping P. G. Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages. Blood 1999; 94(10)3413–3420
   PubMed Web of Science ®Google Scholar
• Poulsen L. K., Jacobsen N., Sorensen B. B., Bergenhem N. C., Kelly J. D., Foster D. C., Thastrup O., Ezban M., Petersen L. C. Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor. J Biol Chem 1998; 273(11)6228–6232
   PubMed Web of Science ®Google Scholar
• Versteeg H. H., Hoedemaeker I., Diks S. H., Stam J. C., Spaargaren M., van Bergen En Henegouwen P. M., van Deventer S. J., Peppelenbosch M. P. Factor VIIa/tissue factor-induced signaling via activation of Src-like kinases, phosphatidylinositol 3-kinase, and Rac. J Biol Chem 2000; 275(37)28750–28756
   PubMed Web of Science ®Google Scholar
• Versteeg H. H., Spek C. A., Slofstra S. H., Diks S. H., Richel D. J., Peppelenbosch M. P. FVIIa:TF induces cell survival via G12/G13-dependent Jak/STAT activation and BclXL production. Circ Res 2004; 94(8)1032–1040
   PubMed Web of Science ®Google Scholar
• Riewald M., Kravchenko V. V., Petrovan R. J., O'Brien P. J., Brass L. F., Ulevitch R. J., Ruf W. Gene induction by coagulation factor Xa is mediated by activation of protease-activated receptor 1. Blood 2001; 97(10)3109–3116
   PubMed Web of Science ®Google Scholar
• Riewald M., Ruf W. Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor. Proc Natl Acad Sci USA 2001; 98(14)7742–7747
   PubMed Web of Science ®Google Scholar
• Jiang X., Bailly M. A., Panetti T. S., Cappello M., Konigsberg W. H., Bromberg M. E. Formation of tissue factor-factor VIIa-factor Xa complex promotes cellular signaling and migration of human breast cancer cells. J Thromb Haemost 2004; 2(1)93–101
   PubMed Web of Science ®Google Scholar
• Albrektsen T., Sorensen B. B., Hjorto G. M., Fleckner J., Rao L. V., Petersen L. C. Transcriptional program induced by factor VIIa-tissue factor, PAR1 and PAR2 in MDA-MB-231 cells. J Thromb Haemost 2007; 5(8)1588–1597
   PubMed Web of Science ®Google Scholar
• Bretschneider E., Braun M., Fischer A., Wittpoth M., Glusa E., Schror K. Factor Xa acts as a PDGF-independent mitogen in human vascular smooth muscle cells. Thromb Haemost 2000; 84(3)499–505
   PubMed Web of Science ®Google Scholar
• Gasic G. P., Arenas C. P., Gasic T. B., Gasic G. J. Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells. Proc Natl Acad Sci USA 1992; 89(6)2317–2320
   PubMed Web of Science ®Google Scholar
• Herbert J., Bono F., Herault J., Avril C., Dol F., Mares A., Schaeffer P. Effector protease receptor 1 mediates the mitogenic activity of factor Xa for vascular smooth muscle cells in vitro and in vivo. J Clin Invest 1998; 101(5)993–1000
   PubMed Web of Science ®Google Scholar
• McLean K., Schirm S., Johns A., Morser J., Light D. R. FXa-induced responses in vascular wall cells are PAR-mediated and inhibited by ZK-807834. Thromb Res 2001; 103(4)281–297
   PubMed Web of Science ®Google Scholar
• Ko F. N., Yang Y. C., Huang S. C., Ou J. T. Coagulation factor Xa stimulates platelet-derived growth factor release and mitogenesis in cultured vascular smooth muscle cells of rat. J Clin Invest 1996; 98(6)1493–1501
   PubMed Web of Science ®Google Scholar
• Altieri D. C. Xa receptor EPR-1. Faseb J 1995; 9(10)860–865
   PubMed Web of Science ®Google Scholar
• Bhattacharjee G., Ahamed J., Pawlinski R., Liu C., Mackman N., Ruf W., Edgington T. S. Factor Xa binding to annexin 2 mediates signal transduction via protease-activated receptor 1. Circ Res 2008; 102(4)457–464
   PubMed Web of Science ®Google Scholar
• Macfarlane S. R., Seatter M. J., Kanke T., Hunter G. D., Plevin R. Proteinase-activated receptors. Pharmacol Rev 2001; 53(2)245–282
   PubMed Web of Science ®Google Scholar
• Patterson C., Stouffer G. A., Madamanchi N., Runge M. S. New tricks for old dogs: nonthrombotic effects of thrombin in vessel wall biology. Circ Res 2001; 88(10)987–997
   PubMed Web of Science ®Google Scholar
• Ishihara H., Connolly A. J., Zeng D., Kahn M. L., Zheng Y. W., Timmons C., Tram T., Coughlin S. R. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 1997; 386(6624)502–506
   PubMed Web of Science ®Google Scholar
• Nakanishi-Matsui M., Zheng Y. W., Sulciner D. J., Weiss E. J., Ludeman M. J., Coughlin S. R. PAR3 is a cofactor for PAR4 activation by thrombin. Nature 2000; 404(6778)609–613
   PubMed Web of Science ®Google Scholar
• O'Brien P. J., Prevost N., Molino M., Hollinger M. K., Woolkalis M. J., Woulfe D. S., Brass L. F. Thrombin responses in human endothelial cells. Contributions from receptors other than PAR1 include the transactivation of PAR2 by thrombin-cleaved PAR1. J Biol Chem 2000; 275(18)13502–13509
   PubMed Web of Science ®Google Scholar
• Griffin C. T., Srinivasan Y., Zheng Y. W., Huang W., Coughlin S. R. A role for thrombin receptor signaling in endothelial cells during embryonic development. Science (New York, N. Y.) 2001; 293(5535)1666–1670
   PubMed Web of Science ®Google Scholar
• Haralabopoulos G. C., Grant D. S., Kleinman H. K., Maragoudakis M. E. Thrombin promotes endothelial cell alignment in Matrigel in vitro and angiogenesis in vivo. Am J Physiol 1997; 273: C239–C245, (1 Pt 1)
   PubMed Web of Science ®Google Scholar
• Maragoudakis M. E., Kraniti N., Giannopoulou E., Alexopoulos K., Matsoukas J. Modulation of angiogenesis and progelatinase a by thrombin receptor mimetics and antagonists. Endothelium 2001; 8(3)195–205
   PubMed Web of Science ®Google Scholar
• Daniel T. O., Gibbs V. C., Milfay D. F., Garovoy M. R., Williams L. T. Thrombin stimulates c-sis gene expression in microvascular endothelial cells. J Biol Chem 1986; 261(21)9579–9582
   PubMed Web of Science ®Google Scholar
• Papadimitriou E., Manolopoulos V. G., Hayman G. T., Maragoudakis M. E., Unsworth B. R., Fenton J. W., 2nd, Lelkes P. I. Thrombin modulates vectorial secretion of extracellular matrix proteins in cultured endothelial cells. Am J Physiol 1997; 272: C1112–1122, (4 Pt 1)
   PubMed Web of Science ®Google Scholar
• Even-Ram S., Uziely B., Cohen P., Grisaru-Granovsky S., Maoz M., Ginzburg Y., Reich R., Vlodavsky I., Bar-Shavit R. Thrombin receptor overexpression in malignant and physiological invasion processes. Nat Med 1998; 4(8)909–914
   PubMed Web of Science ®Google Scholar
• Tsopanoglou N. E., Maragoudakis M. E. On the mechanism of thrombin-induced angiogenesis. Potentiation of vascular endothelial growth factor activity on endothelial cells by up-regulation of its receptors. J Biol Chem 1999; 274(34)23969–23976
   PubMed Web of Science ®Google Scholar
• Wojtukiewicz M. Z., Tang D. G., Ciarelli J. J., Nelson K. K., Walz D. A., Diglio C. A., Mammen E. F., Honn K. V. Thrombin increases the metastatic potential of tumor cells. Int J Cancer 1993; 54(5)793–806
   PubMed Web of Science ®Google Scholar
• Wojtukiewicz M. Z., Tang D. G., Nelson K. K., Walz D. A., Diglio C. A., Honn K. V. Thrombin enhances tumor cell adhesive and metastatic properties via increased alpha IIb beta 3 expression on the cell surface. Thromb Res 1992; 68(3)233–245
   PubMed Web of Science ®Google Scholar
• Hattori R., Hamilton K. K., Fugate R. D., McEver R. P., Sims P. J. Stimulated secretion of endothelial von Willebrand factor is accompanied by rapid redistribution to the cell surface of the intracellular granule membrane protein GMP-140. J Biol Chem 1989; 264(14)7768–7771
   PubMed Web of Science ®Google Scholar
• Stenberg P. E., McEver R. P., Shuman M. A., Jacques Y. V., Bainton D. F. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol 1985; 101(3)880–886
   PubMed Web of Science ®Google Scholar
• Henn V., Slupsky J. R., Grafe M., Anagnostopoulos I., Forster R., Muller-Berghaus G., Kroczek R. A. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391(6667)591–594
   PubMed Web of Science ®Google Scholar
• Yin Y. J., Salah Z., Grisaru-Granovsky S., Cohen I., Even-Ram S. C., Maoz M., Uziely B., Peretz T., Bar-Shavit R. Human protease-activated receptor 1 expression in malignant epithelia: a role in invasiveness. Arterioscler Thromb Vasc Biol 2003; 23(6)940–944
   PubMed Web of Science ®Google Scholar
• Maloney J. P., Silliman C. C., Ambruso D. R., Wang J., Tuder R. M., Voelkel N. F. In vitro release of vascular endothelial growth factor during platelet aggregation. Am J Physiol 1998; 275: H1054–H1061, (3 Pt 2)
   PubMed Web of Science ®Google Scholar
• Mohle R., Green D., Moore M. A., Nachman R. L., Rafii S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci USA 1997; 94(2)663–668
   PubMed Web of Science ®Google Scholar
• Nierodzik M. L., Chen K., Takeshita K., Li J. J., Huang Y. Q., Feng X. S., D'Andrea M. R., Andrade-Gordon P., Karpatkin S. Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis. Blood 1998; 92(10)3694–3700
   PubMed Web of Science ®Google Scholar
• Camerer E., Qazi A. A., Duong D. N., Cornelissen I., Advincula R., Coughlin S. R. Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. Blood 2004; 104(2)397–401
   PubMed Web of Science ®Google Scholar
• Nierodzik M. L., Plotkin A., Kajumo F., Karpatkin S. Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo. J Clin Invest 1991; 87(1)229–236
   PubMed Web of Science ®Google Scholar
• Fischer E. G., Riewald M., Huang H. Y., Miyagi Y., Kubota Y., Mueller B. M., Ruf W. Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor. J Clin Invest 1999; 104(9)1213–1221
   PubMed Web of Science ®Google Scholar
• Karpatkin S. Does hypercoagulability awaken dormant tumor cells in the host?. J Thromb Haemost 2004; 2(12)2103–2106
   PubMed Web of Science ®Google Scholar
• Rickles F. R., Patierno S., Fernandez P. M. Tissue factor, thrombin, and cancer. Chest 2003; 124(Suppl. 3)58S–68S
   PubMed Web of Science ®Google Scholar
• Lalla R. V., Goralnick S. J., Tanzer M. L., Kreutzer D. L. Fibrin induces IL-8 expression from human oral squamous cell carcinoma cells. Oral Oncol 2001; 37(3)234–242
   PubMed Web of Science ®Google Scholar
• Medved L., Tsurupa G., Yakovlev S. Conformational changes upon conversion of fibrinogen into fibrin. The mechanisms of exposure of cryptic sites. Ann N Y Acad Sci 2001; 936: 185–204
   PubMed Web of Science ®Google Scholar
• Degen J. L., Drew A. F., Palumbo J. S., Kombrinck K. W., Bezerra J. A., Danton M. J., Holmback K., Suh T. T. Genetic manipulation of fibrinogen and fibrinolysis in mice. Ann N Y Acad Sci 2001; 936: 276–290
   PubMed Web of Science ®Google Scholar
• van Hinsbergh V. W., Collen A., Koolwijk P. Role of fibrin matrix in angiogenesis. Ann N Y Acad Sci 2001; 936: 426–437
   PubMed Web of Science ®Google Scholar
• Palumbo J. S., Kombrinck K. W., Drew A. F., Grimes T. S., Kiser J. H., Degen J. L., Bugge T. H. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood 2000; 96(10)3302–3309
   PubMed Web of Science ®Google Scholar
• Palumbo J. S., Potter J. M., Kaplan L. S., Talmage K., Jackson D. G., Degen J. L. Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice. Cancer Res 2002; 62(23)6966–6972
   PubMed Web of Science ®Google Scholar
• Hu L., Lee M., Campbell W., Perez-Soler R., Karpatkin S. Role of endogenous thrombin in tumor implantation, seeding, and spontaneous metastasis. Blood 2004; 104(9)2746–2751
   PubMed Web of Science ®Google Scholar
• Bardos H., Molnar P., Csecsei G., Adany R. Fibrin deposition in primary and metastatic human brain tumours. Blood Coagul Fibrinolysis 1996; 7(5)536–548
   PubMed Web of Science ®Google Scholar
• Wojtukiewicz M. Z., Zacharski L. R., Memoli V. A., Kisiel W., Kudryk B. J., Moritz T. E., Rousseau S. M., Stump D. C. Fibrin formation on vessel walls in hyperplastic and malignant prostate tissue. Cancer 1991; 67(5)1377–1383
   PubMed Web of Science ®Google Scholar
• Bootle-Wilbraham C. A., Tazzyman S., Marshall J. M., Lewis C. E. Fibrinogen E-fragment inhibits the migration and tubule formation of human dermal microvascular endothelial cells in vitro. Cancer Res 2000; 60(17)4719–4724
   PubMed Web of Science ®Google Scholar
• Thompson W. D., Smith E. B., Stirk C. M., Marshall F. I., Stout A. J., Kocchar A. Angiogenic activity of fibrin degradation products is located in fibrin fragment E. J Pathol 1992; 168(1)47–53
   PubMed Web of Science ®Google Scholar
• Rickles F. R., Falanga A. Molecular basis for the relationship between thrombosis and cancer. Thromb Res 2001; 102(6)V215–V224
   PubMed Web of Science ®Google Scholar